Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC

Clinical trial NCT03046992 · COMPLETED

Trial details

NCT number: NCT03046992
Sponsor: Yuhan Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

EGFR Gene Mutation

Start date: 2017-02-15
Primary completion: 2021-01-08
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.